Beyond Corp News
News on Beyond Corp (Ticker: BBBY) continually updated from thousands of sources around the net.
8 hrs ago | The Motley Fool
In light of this news, it makes sense for shares to drop. Is it possible though that now more than ever is a prime opportunity to pile into the company? Bed Bath & Below! During the fourth quarter of its 2013 fiscal year, Bed Bath & Beyond reported revenue of $3.2 billion.
Trending on the Topix Network
After shares in the home furnishings giant rallied in the first few years after the Great Recession, stagnation has set in since 2012.
To see what our analysts have discovered about these stocks read the InvestorsObserver's PriceWatch Alerts at http://www.investorsobserver.com/pr/41120141 Today's PriceWatch Alerts cover the following stocks: Prudential , SanDisk , 3M , Bed Bath & Beyond , and CVS Caremark .
Mustang Wanted , meet Don Draper . Much like our aforementioned daredevil , the Nasdaq -- which hit a 14-year high only last month -- had hitherto been on a hair-raising climb.
Looking through the closing trading data for the Russell 1000 components, there are some abnormal volume stand-outs that traders will be interested to watch during Friday's upcoming session.
Fairfield police were called to the Bed Bath and Beyond on Kings Highway East after a man used 10 counterfeit $20 bills to purchase items at the store, police said.
U.S. stocks tumbled Thursday, with the Nasdaq Composite index falling the most since 2011, as a technology selloff resumed amid concern valuations may be too high at the start of earnings season.
After beginning the day on a relatively calm note, the stock market ended the day with a huge plunge, with the Nasdaq suffering its worst decline in almost two-and-a-half years.
A number of other firms have also recently commented on BBBY. Analysts at SunTrust cut their price target on shares of Bed Bath & Beyond from $84.00 to $80.00 in a research note on Thursday.
Traders Randy Beller, left, and William McInerney work on the floor of the New York Stock Exchange Thursday, April 10, 2014.
Wall Street slumped as investors sold, yet again, biotech and internet stocks heading into the quarterly US earnings season, while Bed Bath & Beyond shares took a beating following disappointing results.
Another plunge in the biotechnology sector led stock indexes down Thursday, as Biogen Idec, Gilead Sciences and other biotech companies extended a recent slump.
U.S. stock indexes are slipping lower in early trading as investors pick over a mixed batch of corporate earnings reports.
Shares of Rite Aid Corp. surged in premarket trade Thursday while shares of Bed Bath & Beyond Inc. and eBay Inc. declined.
Trader Stephen McSherry works on the floor of the New York Stock Exchange in this March 12, 2014 file photo.